Brief: Bionaturis Gets Patent For BNT005 In US

Biotechnology Assets SA

07/02/2018 10:30

Feb 7 (Reuters) - BIOORGANIC RESEARCH AND SERVICES SA 
(BIONATURIS)  BNT.MC : 
    * SAYS GETS PATENT IN UNITED STATES FOR ITS MOLECULE USEFUL 
IN 
IMMUNOTHERAPY FOR CANINE LEISHMANIASIS 
    * SAYS GETS 196,300 EURO GRANT TO DEVELOP THE PROJECT, TO 
APPLY 
FOR MARKETING AUTHORIZATION OF BNT005 IN ARGENTINA 
 
 
 
     
 Source text: http://bit.ly/2sfrcCb 
     
 Further company coverage:  BNT.MC   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))